Skip to main content

and
  1. No Access

    Article

    Combined Erlotinib and Cetuximab overcome the acquired resistance to epidermal growth factor receptors tyrosine kinase inhibitor in non-small-cell lung cancer

    Non-small-cell lung cancer (NSCLC) cells with somatic mutations in epidermal growth factor receptors (EGFR) are initially susceptible to tyrosine kinase inhibitor (TKI); however, eventually resistance to TKI i...

    Meng Wang, **g Zhao, Lian-Min Zhang, Hui Li in Journal of Cancer Research and Clinical On… (2012)

  2. Article

    Open Access

    Acylglycerol kinase promotes tumour growth and metastasis via activating the PI3K/AKT/GSK3β signalling pathway in renal cell carcinoma

    Clinically, the median survival in patients with metastatic renal cell carcinoma (RCC) was only 6–12 months and a 5-year survival rate of less than 20%. Therefore, an in-depth study of the molecular mechanisms...

    Qian Zhu, Ai-Lin Zhong, Hao Hu, **g-**g Zhao in Journal of Hematology & Oncology (2020)

  3. Article

    Open Access

    Correction: Acylglycerol kinase promotes tumour growth and metastasis via activating the PI3K/AKT/GSK3β signalling pathway in renal cell carcinoma

    Qian Zhu, Ai-Lin Zhong, Hao Hu, **g-**g Zhao in Journal of Hematology & Oncology (2023)